- Pharmaceutical Products
- Products By Brand Name
- Products By Dosage Form
- Products By Generic Name
- Products By Therapeutic Class
Find a product
Find Generic
Levefix
Levetiracetam USP
Description:
Levefix is a preparation of Levetiracetam, a pyrrolidone derivative, which is an antiseizure (antiepileptic) agent.
Levefix is a preparation of Levetiracetam, a pyrrolidone derivative, which is an antiseizure (antiepileptic) agent.
Indications:
Levefix (Levetiracetam) is indicated as an adjunctive therapy for:
Levefix (Levetiracetam) is indicated as an adjunctive therapy for:
- Partial Onset Seizures
- Myoclonic Seizures in patients with Juvenile Myclonic Epilepsy
- Primary Generalised Tonic-Clonic Seizures
Mode of Action:
The exact mechanism of action of Levetiracetam is unknown but does not involve inhibitory and excitatory neurotransmission. Stereo-selective binding of Levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. It has been suggested that Levetiracetam inhibits burst firing without affecting normal neuronal excitability.
The exact mechanism of action of Levetiracetam is unknown but does not involve inhibitory and excitatory neurotransmission. Stereo-selective binding of Levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. It has been suggested that Levetiracetam inhibits burst firing without affecting normal neuronal excitability.
Other Brands From Same Therapeutic Class
